A case of fetal-onset type 3 familial hemophagocytic lymphohistiocytosis surviving without severe complications after early diagnosis and treatment
Takashi Matsumoto
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorCorresponding Author
Hiroko Fukushima
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Correspondence
Hiroko Fukushima¸ Department of Child Health, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305–8575, Japan.
Email: [email protected]
Search for more papers by this authorSatoshi Fujiyama
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorKumie Nagatomo
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorSho Hosaka
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorRyoko Suzuki
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorYuni Yamaki
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorYu Kanai
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorHirofumi Shibata
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorTakahiro Yasumi
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorKyohei Isshiki
Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
Search for more papers by this authorMotohiro Kato
Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
Search for more papers by this authorYayoi Miyazono
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorHidetoshi Takada
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorTakashi Matsumoto
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorCorresponding Author
Hiroko Fukushima
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Correspondence
Hiroko Fukushima¸ Department of Child Health, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305–8575, Japan.
Email: [email protected]
Search for more papers by this authorSatoshi Fujiyama
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorKumie Nagatomo
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorSho Hosaka
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorRyoko Suzuki
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorYuni Yamaki
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Search for more papers by this authorYu Kanai
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorHirofumi Shibata
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorTakahiro Yasumi
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Search for more papers by this authorKyohei Isshiki
Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
Search for more papers by this authorMotohiro Kato
Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
Search for more papers by this authorYayoi Miyazono
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorHidetoshi Takada
Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan
Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this authorThe abstract for this paper was previously published for the following meeting: The 62nd Annual Meeting of the Japanese Society of Pediatric Hematology Society November 20–22, 2020.

Open Research
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Supporting Information
Filename | Description |
---|---|
pbc29016-sup-0001-Supplementary.docx35.2 KB | Supplementary Material |
pbc29016-sup-0001-SupplementaryTable1.docx19 KB | TABLE S1 Cases of fetal-onset familial hemophagocytic lymphohistiocytosis |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Maruyama A, Takahashi N, Gunji Y, et al. Congenital hemophagocytic lymphohistiocytosis in a preterm infant: cytokine profile and a review of the disease. J Pediatr Hematol Oncol. 2011; 33(5): e209-e212.
- 2Lipton JM, Westra S, Haverty CE, Roberts D, Harris NL. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28–2004. Newborn twins with thrombocytopenia, coagulation defects, and hepatosplenomegaly. N Engl J Med. 2004; 351(11): 1120-1130.
- 3Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48(2): 124-131.
- 4van Gent R, van Tilburg CM, Nibbelke EE, et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol. 2009; 133(1): 95-107.
- 5Ammann S, Lehmberg K, Zur Stadt U, et al. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire. Eur J Immunol. 2017; 47(2): 364-373.
- 6Hoshino A, Xi Y, Nakao T, et al. A cry for the development of newborn screening for familial hemophagocytic lymphohistiocytosis. J Clin Immunol. 2020; 40 1196–1198.
- 7Nitta A, Suzumura H, Watabe Y, et al. Fetal hemophagocytic lymphohistiocytosis in a premature infant. J Pediatr. 2007; 151(1): 98.
- 8Balta G, Topcuoglu S, Gursoy T, Gurgey A, Ovali F. Association of nonimmune hydrops fetalis with familial hemophagocytic lymphohistiocytosis in identical twin neonates with perforin His222Arg (c665A>G) mutation. J Pediatr Hematol Oncol. 2013; 35(8): e332-e334.
- 9Malloy CA, Polinski C, Alkan S, Manera R, Challapalli M. Hemophagocytic lymphohistiocytosis presenting with nonimmune hydrops fetalis. J Perinatol. 2004; 24(7): 458-460.
- 10Levendoglu-Tugal O, Ozkaynak MF, LaGamma E, Sherbany A, Sandoval C, Jayabose S. Hemophagocytic lymphohistiocytosis presenting with thrombocytopenia in the newborn. J Pediatr Hematol Oncol. 2002; 24(5): 405-409.
- 11Stapp J, Wilkerson S, Stewart D, Coventry S, Mo JQ, Bove KE. Fulminant neonatal liver failure in siblings: probable congenital hemophagocytic lymphohistiocytosis. Pediatr Dev Pathol. 2006; 9(3): 239-244.
- 12Yetgin S, Aytac S, Gurakan F, Yurdakok M. Nonimmune hydrops fetalis in two cases of consanguineous parents and associated with hereditary spherocytosis and hemophagocytic hystiocytosis. J Perinatol. 2007; 27(4): 252-254.
- 13Nakao T, Shimizu T, Fukushima T, et al. Fatal sibling cases of familial hemophagocytic lymphohistiocytosis (FHL) with MUNC13-4 mutations: case reports. Pediatr Hematol Oncol. 2008; 25(3): 171-180.
- 14Iwatani S, Uemura K, Mizobuchi M, et al. Familial hemophagocytic lymphohistiocytosis presenting as hydrops fetalis. AJP Rep. 2015; 5(1): e22-e24.
- 15Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol. 1999; 2(4): 360-366.
- 16Vermeulen MJ, de Haas V, Mulder MF, Flohil C, Fetter WP, van de Kamp JM. Hydrops fetalis and early neonatal multiple organ failure in familial hemophagocytic lymphohistiocytosis. Eur J Med Genet. 2009; 52(6): 417-420.
- 17Yasumi T, Hori M, Hiejima E, et al. Laboratory parameters identify familial haemophagocyticlymphohistiocytosis from other forms of paediatrichaemophagocytosis. Br J Haematol. 2015; 170(4): 532-538.
- 18Yanagisawa R, Nakazawa Y, Matsuda K, et al. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan. Int J Hematol. 2019; 109(2): 206-213.
- 19Takada H, Takahata Y, Nomura A, Ohga S, Mizuno Y, Hara T. Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocyticlymphohistiocytosis. Clin Exp Immunol. 2003; 133(3): 448-453.
- 20Gloude NJ, Dandoy CE, Davies SM, et al. Thinking beyond HLH: clinical features of patients with concurrent presentation of hemophagocytic lymphohistiocytosis and thrombotic microangiopathy. J Clin Immunol. 2020; 40(5): 699-707.